Copyright
©The Author(s) 2018.
World J Gastroenterol. Dec 14, 2018; 24(46): 5280-5287
Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5280
Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5280
Table 1 Patient characteristics
Characteristic | Group A | Group B |
Sex, n (%) | ||
Male | 6 (50) | 6 (46.2) |
Female | 6 (50) | 7 (53.8) |
Age, yr | ||
Median (range) | 65.5 (48-81) | 63.8 (47-84) |
Location of lesions, n (%) | ||
Pancreatic head | 11 (92) | 9 (69.2) |
Pancreatic body and tail | 1 (8) | 4 (30.8) |
Lesion size, n (%) | ||
≤ 3 cm | 1 (8.3) | 3 (23.1) |
3-5 cm | 10 (83.3) | 9 (69.2) |
> 5 cm | 1 (8.3) | 1 (7.7) |
Stage, n (%) | ||
III | 7 (58.3) | 8 (61.5) |
IV | 5 (41.6) | 5 (38.5) |
Table 2 Preoperative and postoperative dosimetric data
Group A | Group B | |||||
Dosimeter | Preoperative | Postoperative | P value | Preoperative | Postoperative | P value |
D90 (Gy) | 155.32 ± 8.05 | 154.82 ± 16.43 | 0.91 | 154.2 ± 9.08 | 103.27 ± 25.03 | 0.00 |
V90 (%) | 97.14 ± 0.93 | 94.64 ± 2.35 | 0.01 | 97.17 ± 0.95 | 78.91 ± 12.71 | 0.00 |
V100 (%) | 94.51 ± 1.61 | 91.05 ± 4.06 | 0.02 | 94.94 ± 1.05 | 72.91 ± 13.78 | 0.00 |
V150 (%) | 59.26 ± 15.42 | 64.54 ± 13.40 | 0.36 | 62.44 ± 8.66 | 48.16 ± 15.97 | 0.02 |
Table 3 Differences in postoperative dosimeter values between group A and group B
Postoperative dosimeter | Group A | Group B | t | P value |
D90 (Gy) | 154.82 ± 16.43 | 103.27 ± 25.03 | 6.132 | 0.13 |
V90 (%) | 94.64 ± 2.35 | 78.91 ± 12.71 | 4.38 | 0.00 |
V100 (%) | 91.05 ± 4.06 | 72.91 ± 13.78 | 4.54 | 0.00 |
V150 (%) | 64.54 ± 13.40 | 48.16 ± 15.97 | 2.765 | 0.44 |
- Citation: Huang W, Lu J, Chen KM, Wu ZY, Wang QB, Liu JJ, Gong J, Chen ZJ, Ding XY, Wang ZM. Preliminary application of 3D-printed coplanar template for iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. World J Gastroenterol 2018; 24(46): 5280-5287
- URL: https://www.wjgnet.com/1007-9327/full/v24/i46/5280.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i46.5280